+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global PCOS Treatment Market, By Surgery (Ovarian Wedge Resection, Cyst Aspiration, Laparoscopic Ovarian Drilling), By Drug (Ovulation Inducing Agents, Insulin-Sensitizing Agents, Others), By Diagnosis, By End User, By Region, Forecast & Opportunities, 2025

  • ID: 5022580
  • Report
  • January 2021
  • Region: Global
  • 114 pages
  • TechSci Research
The Global PCOS Treatment Market Was Valued Around USD 3.39 Billion in 2019 and is Expected to Grow at a Formidable Rate of Around 8.63% During the Forecast Period

FEATURED COMPANIES

  • Abbott Laboratories, Inc.
  • AstraZeneca Plc
  • Bayer AG
  • Merck & Co., Inc.
  • Novartis AG
  • Pfizer, Inc.
Free Webex Call

Speak directly to the analyst to clarify any post sales queries you may have.

10% Free customization

This report comes with 10% free customization, enabling you to add data that meets your specific business needs.

The Global PCOS Treatment Market valued around USD 3.39 Billion in 2019 and is expected to grow at a formidable rate of around 8.63% during the forecast period.

The Global PCOS Treatment Market is driven by the increasing prevalence of diabetes and obesity among the woman population. Additionally, increasing cases of hormonal imbalances in the women are further expected to propel the market during forecast period. Furthermore, the development of new drugs and treatment options for the treatment of PCOS is expected to fuel the growth of the market through 2025.

The Global PCOS Treatment Market is segmented based on surgery, drug, diagnosis, End-user, company and region. Based on surgery, the market can be categorized into ovarian wedge resection, cyst aspiration and laparoscopic ovarian drilling. The laparoscopic ovarian drilling segment is expected to dominate the market during forecast years. This can be attributed to the fertility problems faced by the women due to this problem and the response to medications generally weakens over time in women. Additionally, this procedure is cost effective and easy to perform which is driving the growth of segment across the globe.

Regionally, the Global PCOS Treatment Market has been segmented into Asia-Pacific, North America, South America, Europe, and Middle East & Africa. Among these, North America is expected to dominate the Global PCOS Treatment Market owing to the growing prevalence of overweight and obese women population in the region.

Major players operating in the Global PCOS Treatment Market include Bristol-Myers Squibb Company, Bayer AG, Pfizer, Inc., Abbott Laboratories, Inc., Merck & Co., Inc., Sanofi SA, AstraZeneca Plc, Novartis AG, Teva Pharmaceutical Industries Limited, Ferring Pharmaceuticals, Inc., and others. The companies are developing advanced technologies and launching new services in order to stay competitive in the market. Other competitive strategies include mergers & acquisitions and new product developments.

Years considered for this report:
Historical Years: 2015-2018
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2021–2025

Objective of the Study:
  • To analyze and estimate the market size of the Global PCOS Treatment Market from 2015 to 2018.
  • To estimate and forecast the market size of the Global PCOS Treatment Market from 2019 to 2025 and growth rate until 2025.
  • To classify and forecast the Global PCOS Treatment Market based on treatment, diagnosis, End-user, company and regional distribution.
  • To identify dominant region or segment in the Global PCOS Treatment Market.
  • To identify drivers and challenges for the Global PCOS Treatment Market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in the Global PCOS Treatment Market.
  • To identify and analyze the profile of leading players operating in the Global PCOS Treatment Market.
  • To identify key sustainable strategies adopted by market players in the Global PCOS Treatment Market.
The analyst performed both primary as well as exhaustive secondary research for this study. Initially, the analyst sourced a list of hospitals & clinics, ambulatory surgical centers, fertility clinics across the globe. Subsequently, the analyst conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, the analyst could include the hospitals & clinics, ambulatory surgical centers, fertility clinics which could not be identified due to the limitations of secondary research. The publisher analyzed the hospitals & clinics, ambulatory surgical centers, fertility clinics and presence of all major players across the globe.

The analyst calculated the market size of the Global PCOS Treatment Market by using a bottom-up approach, wherein data for various End-user segments was recorded and forecast for the future years. The analyst sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by the analyst.

Key Target Audience:
  • PCOS treatment hospitals & clinics, ambulatory surgical centers, fertility centers and other stakeholders
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to PCOS treatment
Market Research and Consulting Firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as hospitals & clinics, ambulatory surgery centers, fertility clinics, end users, etc., besides allowing them in strategizing investments and capitalizing on the market opportunities.

Report Scope

In this report, the Global PCOS Treatment Market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

Global PCOS Treatment Market, By Surgery:

Global PCOS Treatment Market, By Drug:

Global PCOS Treatment Market, By Diagnosis:
  • Pelvic Examination
  • Ultrasound
  • Blood Tests
Global PCOS Treatment Market, By End-user:
  • Hospitals & Clinics
  • Ambulatory Surgical Centers
  • Fertility Clinics
Global PCOS Treatment Market, By Region:
  • North America
  • Europe
  • Asia-Pacific
  • Middle East & Africa
  • South America
Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global PCOS Treatment Market.

Available Customizations:

With the given market data, the analyst offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information
  • Detailed analysis and profiling of additional market players (up to five).

This report will be delivered within 3 business days and will include the latest impact analysis of COVID-19.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abbott Laboratories, Inc.
  • AstraZeneca Plc
  • Bayer AG
  • Merck & Co., Inc.
  • Novartis AG
  • Pfizer, Inc.
1. Product Overview

2. Research Methodology

3. Impact of COVID-19 on Global PCOS Treatment Market

4. Executive Summary

5. Voice of Customer

6. Global PCOS Treatment Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Surgery (Ovarian Wedge Resection, Cyst Aspiration, Laparoscopic Ovarian Drilling)
6.2.2. By Drug (Ovulation Inducing Agents, Insulin-Sensitizing Agents, Oral Contraceptives, Antiandrogens, Anti-Depressants, Insulin-Sensitizing Agents, Anti-Obesity Drugs, Others)
6.2.3. By Diagnosis (Pelvic Examination, Ultrasound, Blood Tests)
6.2.4. By End-user (Hospitals & Clinics, Ambulatory Surgical Centers, Fertility Clinics)
6.2.5. By Company (2019)
6.2.6. By Region
6.3. Product Market Map

7. Asia-Pacific PCOS Treatment Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Surgery
7.2.2. By Drug
7.2.3. By Diagnosis
7.2.4. By End-user
7.2.5. By Country
7.3. Asia-Pacific: Country Analysis
7.3.1. China PCOS Treatment Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Surgery
7.3.1.2.2. By Drug
7.3.1.2.3. By Diagnosis
7.3.1.2.4. By End-user
7.3.2. India PCOS Treatment Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Surgery
7.3.2.2.2. By Drug
7.3.2.2.3. By Diagnosis
7.3.2.2.4. By End-user
7.3.3. Australia PCOS Treatment Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Surgery
7.3.3.2.2. By Drug
7.3.3.2.3. By Diagnosis
7.3.3.2.4. By End-user
7.3.4. Japan PCOS Treatment Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Surgery
7.3.4.2.2. By Drug
7.3.4.2.3. By Diagnosis
7.3.4.2.4. By End-user
7.3.5. South Korea PCOS Treatment Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Surgery
7.3.5.2.2. By Drug
7.3.5.2.3. By Diagnosis
7.3.5.2.4. By End-user

8. Europe PCOS Treatment Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Surgery
8.2.2. By Drug
8.2.3. By Diagnosis
8.2.4. By End-user
8.2.5. By Country
8.3. Europe: Country Analysis
8.3.1. France PCOS Treatment Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Surgery
8.3.1.2.2. By Drug
8.3.1.2.3. By Diagnosis
8.3.1.2.4. By End-user
8.3.2. Germany PCOS Treatment Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Surgery
8.3.2.2.2. By Drug
8.3.2.2.3. By Diagnosis
8.3.2.2.4. By End-user
8.3.3. United Kingdom PCOS Treatment Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Surgery
8.3.3.2.2. By Drug
8.3.3.2.3. By Diagnosis
8.3.3.2.4. By End-user
8.3.4. Italy PCOS Treatment Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Surgery
8.3.4.2.2. By Drug
8.3.4.2.3. By Diagnosis
8.3.4.2.4. By End-user
8.3.5. Spain PCOS Treatment Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Surgery
8.3.5.2.2. By Drug
8.3.5.2.3. By Diagnosis
8.3.5.2.4. By End-user

9. North America PCOS Treatment Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Surgery
9.2.2. By Drug
9.2.3. By Diagnosis
9.2.4. By End-user
9.2.5. By Country
9.3. North America: Country Analysis
9.3.1. United States PCOS Treatment Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Surgery
9.3.1.2.2. By Drug
9.3.1.2.3. By Diagnosis
9.3.1.2.4. By End-user
9.3.2. Mexico PCOS Treatment Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Surgery
9.3.2.2.2. By Drug
9.3.2.2.3. By Diagnosis
9.3.2.2.4. By End-user
9.3.3. Canada PCOS Treatment Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Surgery
9.3.3.2.2. By Drug
9.3.3.2.3. By Diagnosis
9.3.3.2.4. By End-user

10. South America PCOS Treatment Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Surgery
10.2.2. By Drug
10.2.3. By Diagnosis
10.2.4. By End-user
10.2.5. By Country
10.3. South America: Country Analysis
10.3.1. Brazil PCOS Treatment Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Surgery
10.3.1.2.2. By Drug
10.3.1.2.3. By Diagnosis
10.3.1.2.4. By End-user
10.3.2. Argentina PCOS Treatment Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Surgery
10.3.2.2.2. By Drug
10.3.2.2.3. By Diagnosis
10.3.2.2.4. By End-user
10.3.3. Colombia PCOS Treatment Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Surgery
10.3.3.2.2. By Drug
10.3.3.2.3. By Diagnosis
10.3.3.2.4. By End-user

11. Middle East and Africa PCOS Treatment Market Outlook
11.1. Market Size & Forecast
11.1.1. By Value
11.2. Market Share & Forecast
11.2.1. By Surgery
11.2.2. By Drug
11.2.3. By Diagnosis
11.2.4. By End-user
11.2.5. By Country
11.3. MEA: Country Analysis
11.3.1. South Africa PCOS Treatment Market Outlook
11.3.1.1. Market Size & Forecast
11.3.1.1.1. By Value
11.3.1.2. Market Share & Forecast
11.3.1.2.1. By Surgery
11.3.1.2.2. By Drug
11.3.1.2.3. By Diagnosis
11.3.1.2.4. By End-user
11.3.2. Saudi Arabia PCOS Treatment Market Outlook
11.3.2.1. Market Size & Forecast
11.3.2.1.1. By Value
11.3.2.2. Market Share & Forecast
11.3.2.2.1. By Surgery
11.3.2.2.2. By Drug
11.3.2.2.3. By Diagnosis
11.3.2.2.4. By End-user
11.3.3. UAE PCOS Treatment Market Outlook
11.3.3.1. Market Size & Forecast
11.3.3.1.1. By Value
11.3.3.2. Market Share & Forecast
11.3.3.2.1. By Surgery
11.3.3.2.2. By Drug
11.3.3.2.3. By Diagnosis
11.3.3.2.4. By End-user

12. Market Dynamics
12.1. Drivers
12.2. Challenges

13. Market Trends & Developments

14. Commonly Used PCOS Drugs to control different symptoms

15. Competitive Landscape
15.1. Bristol-Myers Squibb Company
15.2. Bayer AG
15.3. Pfizer, Inc.
15.4. Abbott Laboratories, Inc.
15.5. Merck & Co., Inc.
15.6. Sanofi SA
15.7. AstraZeneca PLC
15.8. Novartis AG
15.9. Teva Pharmaceutical Industries Limited
15.10. Ferring Pharmaceuticals, Inc.

16. Strategic Recommendations

17. About Us & Disclaimer

List of Figures
Figure 1. Global PCOS Treatment Market, By Value, 2015-2025
Figure 2. Global PCOS Treatment Market Share, By Surgery, By Value, 2015-2025
Figure 3. Global PCOS Treatment Market Share, By Drug, By Value, 2015-2025
Figure 4. Global PCOS Treatment Market Share, By Diagnosis, By Value, 2015-2025
Figure 5. Global PCOS Treatment Market Share, By End-user, By Value, 2015-2025
Figure 6. Global PCOS Treatment Market Share, By Company, By Value, 2015-2025
Figure 7. Global PCOS Treatment Market Share, By Region, By Value, 2015-2025
Figure 8. North America PCOS Treatment Market, By Value, 2015-2025
Figure 9. North America PCOS Treatment Market Share, By Surgery, By Value, 2015-2025
Figure 10. North America PCOS Treatment Market Share, By Drug, By Value, 2015-2025
Figure 11. North America PCOS Treatment Market Share, By Diagnosis, By Value, 2015-2025
Figure 12. North America PCOS Treatment Market Share, By End-user, By Value, 2015-2025
Figure 13. North America PCOS Treatment Market Share, By Country, By Value, 2015-2025
Figure 14. Europe PCOS Treatment Market, By Value, 2015-2025
Figure 15. Europe PCOS Treatment Market Share, By Surgery, By Value, 2015-2025
Figure 16. Europe PCOS Treatment Market Share, By Drug, By Value, 2015-2025
Figure 17. Europe PCOS Treatment Market Share, By Diagnosis, By Value, 2015-2025
Figure 18. Europe PCOS Treatment Market Share, By End-user, By Value, 2015-2025
Figure 19. Europe PCOS Treatment Market Share, By Country, By Value, 2015-2025
Figure 20. Asia Pacific PCOS Treatment Market, By Value, 2015-2025
Figure 21. Asia Pacific PCOS Treatment Market Share, By Surgery, By Value, 2015-2025
Figure 22. Asia Pacific PCOS Treatment Market Share, By Drug, By Value, 2015-2025
Figure 23. Asia Pacific PCOS Treatment Market Share, By Diagnosis, By Value, 2015-2025
Figure 24. Asia Pacific PCOS Treatment Market Share, By End-user, By Value, 2015-2025
Figure 25. Asia Pacific PCOS Treatment Market Share, By Country, By Value, 2015-2025
Figure 26. MEA PCOS Treatment Market, By Value, 2015-2025
Figure 27. MEA PCOS Treatment Market Share, By Surgery, By Value, 2015-2025
Figure 28. MEA PCOS Treatment Market Share, By Drug, By Value, 2015-2025
Figure 29. MEA PCOS Treatment Market Share, By Diagnosis, By Value, 2015-2025
Figure 30. MEA PCOS Treatment Market Share, By End-user, By Value, 2015-2025
Figure 31. MEA PCOS Treatment Market Share, By Country, By Value, 2015-2025
Figure 32. South America PCOS Treatment Market, By Value, 2015-2025
Figure 33. South America PCOS Treatment Market Share, By Surgery, By Value, 2015-2025
Figure 34. South America PCOS Treatment Market Share, By Drug, By Value, 2015-2025
Figure 35. South America PCOS Treatment Market Share, By Diagnosis, By Value, 2015-2025
Figure 36. South America PCOS Treatment Market Share, By End-user, By Value, 2015-2025
Figure 37. South America PCOS Treatment Market Share, By Country, By Value, 2015-2025

List of Tables
Table 1: Drugs Used for controlling various symptoms of PCOS
Note: Product cover images may vary from those shown
  • Bristol-Myers Squibb Company
  • Bayer AG
  • Pfizer, Inc.
  • Abbott Laboratories, Inc.
  • Merck & Co., Inc.
  • Sanofi SA
  • AstraZeneca Plc
  • Novartis AG
  • Teva Pharmaceutical Industries Limited
  • Ferring Pharmaceuticals, Inc.
Note: Product cover images may vary from those shown
Adroll
adroll